title: Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity.
abstract: Understanding the epidemiology and clinical course of tuberculosis is hampered by the absence of a perfect test for latent tuberculosis infection. The tuberculin skin test (TST) is widely used but suffers poor specificity in those receiving the bacille Calmette-Guérin vaccine and poor sensitivity in individuals with human immunodeficiency virus (HIV) infections. TST responses for a target population in Harare, Zimbabwe (HIV prevalence, 21%), recruited in 2005-2006, were interpreted by using a separate calibration population in Harare, for which interferon-gamma release assays (enzyme-linked immunosorbent spot (ELISpot)) results were also known. Statistical fitting of the responses in the calibration population allowed computation of the probability that an individual in the target population with a given TST and HIV result would have tested ELISpot positive. From this, estimates of the prevalence of tuberculosis infection, and optimal TST cutpoints to minimize misdiagnosis, were computed for different assumptions about ELISpot performance. Different assumptions about the sensitivity and specificity of ELISpot gave a 40%-57% prevalence of tuberculosis infection in the target population (including HIV-infected individuals) and optimal TST cutpoints typically in the 10 mm-20 mm range. However, the optimal cutpoint for HIV-infected individuals was consistently 0 mm. This calibration method may provide a valuable tool for interpreting TST results in other populations.
authors.affiliation: Department of Infectious Disease Epidemiology, St. Mary's Medical School, Imperial College London, Norfolk Place, London W2 1PG, United Kingdom. peter.dodd@imperial.ac.uk
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Dodd
authors.forename: Kerry A
authors.initials: KA
authors.lastname: Millington
authors.forename: Azra C
authors.initials: AC
authors.lastname: Ghani
authors.forename: Junior
authors.initials: J
authors.lastname: Mutsvangwa
authors.forename: Anthony E
authors.initials: AE
authors.lastname: Butterworth
authors.forename: Ajit
authors.initials: A
authors.lastname: Lalvani
authors.forename: Elizabeth L
authors.initials: EL
authors.lastname: Corbett
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000453:epidemiology* / Q000821:virology; D011237:Predictive Value of Tests; D015995:Prevalence; D015203:Reproducibility of Results; D012307:Risk Factors; D014374:Tuberculin Test; D015030:Zimbabwe
references.citation: Clin Exp Immunol. 2007 Nov;150(2):238-44
references.pmid: 17672869
references.citation: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171
references.pmid: 20091503
references.citation: Am J Respir Crit Care Med. 2007 Mar 15;175(6):618-27
references.pmid: 17170386
references.citation: Clin Infect Dis. 2009 Feb 1;48(3):302-12
references.pmid: 19123864
references.citation: AIDS. 2006 Apr 4;20(6):915-21
references.pmid: 16549977
references.citation: Am J Respir Crit Care Med. 2007 Apr 1;175(7):737-42
references.pmid: 17218620
references.citation: AIDS. 2005 Nov 18;19(17):2038-41
references.pmid: 16260914
references.citation: Lancet. 2003 Apr 5;361(9364):1168-73
references.pmid: 12686038
references.citation: AIDS. 2003 May 2;17(7):1102-4
references.pmid: 12700468
references.citation: PLoS One. 2008 Jan 16;3(1):e1441
references.pmid: 18197251
references.citation: PLoS Med. 2006 Jul;3(7):e238
references.pmid: 16796402
references.citation: Clin Infect Dis. 2006 Sep 1;43(5):634-9
references.pmid: 16886159
references.citation: Tuber Lung Dis. 1995 Apr;76(2):114-21
references.pmid: 7780092
references.citation: Lancet. 2006 Mar 18;367(9514):926-37
references.pmid: 16546541
references.citation: J Infect Dis. 2007 Aug 15;196 Suppl 1:S52-62
references.pmid: 17624827
references.citation: Am Rev Respir Dis. 1969 Apr;99(4):Suppl:1-132
references.pmid: 5767603
references.citation: Int J Tuberc Lung Dis. 2009 Oct;13(10):1231-7
references.pmid: 19793427
references.citation: Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47
references.pmid: 10764341
references.citation: Ann Intern Med. 2008 Aug 5;149(3):177-84
references.pmid: 18593687
references.citation: Int J Tuberc Lung Dis. 2008 Aug;12(8):895-902
references.pmid: 18647448
references.citation: Am J Respir Crit Care Med. 2007 Mar 1;175(5):514-20
references.pmid: 17158278
references.citation: Chest. 2007 Jun;131(6):1898-906
references.pmid: 17565023
references.citation: Clin Infect Dis. 2009 Apr 1;48(7):954-62
references.pmid: 19245343
references.citation: Ann Intern Med. 2008 Dec 2;149(11):777-87
references.pmid: 18936496
references.citation: Respir Res. 2006 Apr 01;7:56
references.pmid: 16579856
references.citation: Am J Respir Crit Care Med. 1999 Jan;159(1):15-21
references.pmid: 9872812
references.citation: JAMA. 1999 Aug 18;282(7):677-86
references.pmid: 10517722
references.citation: BMC Infect Dis. 2007 Aug 28;7:99
references.pmid: 17725839
references.citation: Am J Respir Crit Care Med. 2008 May 15;177(10):1164-70
references.pmid: 18276940